Zydus Lifesciences Limited — Updates, 05-11-2025: Press Release
05-11-2025 | 11:13 am
05-11-2025 | 11:13 am
Zydus's Ahmedabad SEZ II plant cleared a USFDA Pre-Approval Inspection (PAI) with NIL observations and 'No Action Indicated' (NAI) classification. This positive operational update signals regulatory compliance for future approvals and derisks operations.
No comments yet. Be the first to comment!
